Objective To perform systematic assessment of ovarian reserve markers using a combination of tests in juvenile systemic lupus erythematosus (JSLE) patients without amenorrhoea. Methods Twenty-seven consecutive JSLE female patients and 13 healthy controls without amenorrhoea were evaluated for 6 months. Ovarian reserve was assessed during early follicular phase by serum levels of follicle stimulating hormone (FSH), luteinising hormone (LH), estradiol, inhibin A, inhibin B and anti-Mullerian hormone (AMH). Ovarian size was measured by abdominal ultrasonography. Demographic data, disease activity, damage and treatment were also analysed. Results The median of current age was similar in ISLE patients and controls (16.5 vs. 15years, p=0.31) with...
Menstrual cycles of 30 patients with juvenile systemic lupus erythematosus (JSLE) were compared with...
Objective. To determine the incidence of ovarian failure after cyclophosphamide (CYC) treatment for ...
OBJECTIVE: The Euro-Lupus regimen of low-dose intravenous cyclophosphamide (IV CYC) (cumulative dose...
Objective To perform systematic assessment of ovarian reserve markers using a combination of tests i...
Objetivo: avaliar marcadores de reserva ovariana e a presença de anticorpo anti-corpo lúteo (anti-Co...
Objective: Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune disorder where the...
Objective. To study the effects of ovarian failure on disease flares in systemic lupus erythematosus...
Introduction Systemic lupus erythematosus (SLE) is a chronic autoimmune systemic disease that mainly...
The objective of this study was to determine the frequency and risk factors of early ovarian failure...
Objective. To evaluate whether a short duration treatment with cyclophosphamide (CYC) followed by my...
The objective of this study was to determine the frequency and risk factors of early ovarian failure...
Objective Cyclophosphamide (CYC) therapy for systemic lupus erythematosus (SLE), a disease predomin...
oO hormônio anti-Mülleriano (HAM) é secretado a partir das células da granulosa dos folícu-los ovari...
AbstractThe anti-Müllerian hormone (AMH) is secreted from granulosa cells of growing ovarian follicl...
To identify the underlying mechanism of amenorrhea in juvenile systemic lupus erythematosus (JSLE) p...
Menstrual cycles of 30 patients with juvenile systemic lupus erythematosus (JSLE) were compared with...
Objective. To determine the incidence of ovarian failure after cyclophosphamide (CYC) treatment for ...
OBJECTIVE: The Euro-Lupus regimen of low-dose intravenous cyclophosphamide (IV CYC) (cumulative dose...
Objective To perform systematic assessment of ovarian reserve markers using a combination of tests i...
Objetivo: avaliar marcadores de reserva ovariana e a presença de anticorpo anti-corpo lúteo (anti-Co...
Objective: Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune disorder where the...
Objective. To study the effects of ovarian failure on disease flares in systemic lupus erythematosus...
Introduction Systemic lupus erythematosus (SLE) is a chronic autoimmune systemic disease that mainly...
The objective of this study was to determine the frequency and risk factors of early ovarian failure...
Objective. To evaluate whether a short duration treatment with cyclophosphamide (CYC) followed by my...
The objective of this study was to determine the frequency and risk factors of early ovarian failure...
Objective Cyclophosphamide (CYC) therapy for systemic lupus erythematosus (SLE), a disease predomin...
oO hormônio anti-Mülleriano (HAM) é secretado a partir das células da granulosa dos folícu-los ovari...
AbstractThe anti-Müllerian hormone (AMH) is secreted from granulosa cells of growing ovarian follicl...
To identify the underlying mechanism of amenorrhea in juvenile systemic lupus erythematosus (JSLE) p...
Menstrual cycles of 30 patients with juvenile systemic lupus erythematosus (JSLE) were compared with...
Objective. To determine the incidence of ovarian failure after cyclophosphamide (CYC) treatment for ...
OBJECTIVE: The Euro-Lupus regimen of low-dose intravenous cyclophosphamide (IV CYC) (cumulative dose...